< Decision ExIV/1: 2021 contributions to the Multilateral Fund for the Implementation of the Montreal Protocol for the triennium 2021–2023 Up one level Decision XXXII/1: Interim budget for the Multilateral Fund for the Implementation of the Montreal Protocol for the triennium 2021–2023 > Thirty-Second Meeting of the Parties Decision XXXII/1: Interim budget for the Multilateral Fund for the Implementation of the Montreal Protocol for the triennium 2021–2023 Decision XXXII/2: Extraordinary meeting of the parties in 2021 Decision XXXII/3: Critical-use exemptions for methyl bromide for 2021 and 2022 Decision XXXII/4: Data and information provided by the parties in accordance with Article 7 of the Montreal Protocol Decision XXXII/5: Reporting of information on the use of controlled substances as process agents Decision XXXII/6: Democratic People’s Republic of Korea Decision XXXII/7: Membership changes on the Technology and Economic Assessment Panel Decision XXXII/8: Membership of the Implementation Committee Decision XXXII/9: Membership of the Executive Committee of the Multilateral Fund Decision XXXII/10: Co-chairs of the Open ended Working Group of the Parties to the Montreal Protocol Decision XXXII/11: Thirty Third Meeting of the Parties to the Montreal Protocol Decision XXXII/12: Financial reports and budgets for the Montreal Protocol Annex: Summaries of presentations by members of the assessments panels and the technical options committees < Decision ExIV/1: 2021 contributions to the Multilateral Fund for the Implementation of the Montreal Protocol for the triennium 2021–2023 Up one level Decision XXXII/1: Interim budget for the Multilateral Fund for the Implementation of the Montreal Protocol for the triennium 2021–2023 >
